SBRT to adrenal metastases provides high local control with minimal toxicity.

about

SBRT to adrenal metastases provides high local control with minimal toxicity.

Item

http://www.wikidata.org/entity/Q47275101

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

SBRT to adrenal metastases provides high local control with minimal toxicity.

@en

SBRT to adrenal metastases provides high local control with minimal toxicity.

@nl

type

Item

label

SBRT to adrenal metastases provides high local control with minimal toxicity.

@en

SBRT to adrenal metastases provides high local control with minimal toxicity.

@nl

prefLabel

SBRT to adrenal metastases provides high local control with minimal toxicity.

@en

SBRT to adrenal metastases provides high local control with minimal toxicity.

@nl

P1476

SBRT to adrenal metastases provides high local control with minimal toxicity

@en

P2093

Gerald H Clamon

http://www.w3.org/2001/XMLSchema#string

Nathan Camden

http://www.w3.org/2001/XMLSchema#string

Sudershan K Bhatia

http://www.w3.org/2001/XMLSchema#string

Taher Abu Hejleh

http://www.w3.org/2001/XMLSchema#string

P2860

Review and uses of stereotactic body radiation therapy for oligometastases

SBRT: A viable option for treating adrenal gland metastases

Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.

Treating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experience

A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience

Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors.

Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.

Stereotactic body radiotherapy in the treatment of adrenal metastases.

P304

581-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADRO.2017.07.011

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204525

http://www.w3.org/2001/XMLSchema#string

P932

5707423

http://www.w3.org/2001/XMLSchema#string